Table 3

Predictors of the composite of survival and freedom of cardiac adverse events

ßP valueHRCI
Impact of BSA-adjusted tenting area
 Age0.000.981.000.97 to 1.03
 Log. EuroScore II0.020.041.020.99 to 1.05
 Coronary disease0.680.021.971.14 to 3.40
 Creatinine level0.100.441.100.86 to 1.43
 LVEF−0.030.010.970.95 to 0.99
 Tenting area/BSA*0.670.021.941.09 to 3.47
Impact of BSA-adjusted tenting area >1.35 cm2/m2
 Age−0.020.870.990.97 to 1.03
 Log. EuroScore II0.020.101.021.00 to 1.05
 Coronary disease0.690.012.001.16 to 3.41
 Creatinine level0.080.561.080.83 to 1.40
 LVEF−0.030.010.970.95 to 0.99
 Tenting area/BSA
 >1.35 cm2/m2
0.840.0032.311.32 to 4.04
Impact of annulus-adjusted tenting area
 Age0.000.991.000.97 to 1.03
 Log. EuroScore II0.020.191.020.99 to 1.05
 Coronary disease0.580.031.791.05 to 3.06
 Creatinine level0.120.371.120.87 to 1.45
 LVEF−0.030.0040.970.95 to 0.99
 Tenting area/annulus*1.040.172.840.64 to 12.6
Impact of annulus-adjusted tenting area >0.76 cm2/cm
 Age−0.010.961.000.97 to 1.03
 Log. EuroScore II0.020.171.020.99 to 1.05
 Coronary disease0.580.031.791.05 to 3.06
 Creatinine level0.090.471.100.85 to 1.42
 LVEF−0.030.010.970.95 to 0.99
 Tenting area/annulus
 >0.76 cm2/cm†
0.550.0371.721.03 to 2.89
Impact of gender
 Age−0.010.930.990.97 to 1.03
 Log. EuroScore II0.020.211.020.99 to 1.04
 Coronary disease0.500.081.650.95 to 2.87
 Creatinine level0.120.381.120.87 to 1.45
 LVEF−0.030.0030.970.95 to 0.99
 Female sex−0.180.510.830.48 to 1.44
  • Independent predictors of the composite of survival and freedom from adverse cardiac events were assessed by multivariable analysis using the Cox proportional hazards regression model.

  • *Continuous variable.

  • †Dichotomised variable.

  • BSA, body surface area; LVEF, left ventricle ejection fraction.